Latest Artificial Intelligence News

Orcoda Limited announces a pivotal leadership transition with Patrick Bodegraven stepping in as Managing Director, while long-serving Geoff Jamieson shifts to a part-time CFO role to support continuity.

Centrepoint Alliance has reported record FY25 financial results, driven by strong organic growth, strategic acquisitions, and early adoption of AI technology. The company’s outlook for FY26 remains positive with increased EBITDA guidance and continued expansion in higher-margin segments.

Artrya Limited has expanded its SAPPHIRE clinical study with Ascension, one of the largest US non-profit health systems, joining as the fourth major participant. This move strengthens the study’s reach and advances the evaluation of Artrya’s AI-powered Salix platform for coronary artery disease detection.

Xero Limited reported a robust first half of FY26 with 20% revenue growth and a 42% jump in net profit, driven by the strategic acquisition of Melio and expanded AI capabilities.

DigiCo Infrastructure REIT has reported a strong inaugural year, exceeding EBITDA guidance and accelerating capacity expansions in Australia and the US, positioning itself to capitalise on surging AI-driven data centre demand.

Pathkey.AI has teamed up with Armstrong Clinical to blend AI-driven trial predictions with expert clinical strategy, aiming to boost early-phase trial success and accelerate drug development in Australia and beyond.

Flight Centre Travel Group reported a profit shortfall in FY25 but remains optimistic for FY26, driven by strategic investments, AI integration, and a diversified global portfolio.

Carnegie Clean Energy's subsidiary has received a significant milestone payment under the EuropeWave contract, marking progress in deploying its wave energy technology at a key European marine site.

L1 Long Short Fund reported a 7.2% net return for FY2024-25 and announced a shift to quarterly dividends, reflecting confidence despite a challenging market environment.

OFX Group reported a 5.6% decline in net operating income for 1H26 amid macroeconomic challenges but showcased strong progress in its OFX 2.0 platform transition and strategic investments aimed at long-term growth.

Archer Materials has partnered with CSIRO to develop cutting-edge quantum machine learning models aimed at revolutionizing fraud detection in financial transactions.

Algorae Pharmaceuticals has launched AlgoraeOS Version 2, a major AI platform upgrade that surpasses leading models including those from Google DeepMind, promising to accelerate drug-combination discovery.